A magic bullet for mucosal protection…and aspirin is the trigger!

This publication has 19 references indexed in Scilit:

• Evidence that 5‐lipoxygenase and acetylated cyclooxygenase 2‐derived eicosanoids regulate leukocyte–endothelial adherence in response to aspirin
  British Journal of Pharmacology, 2003
• Celecoxib exacerbates gastrointestinal damage induced by aspirin but not by no-aspirin (NCX-4016): A randomised, parallel group, blind-observer endoscopic study. Evidence for a protective role of no in the gastrointestinal mucosa
  Gastroenterology, 2003
• The development of COX2 inhibitors
  Nature Reviews Drug Discovery, 2003
• Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor
  Nature Medicine, 2002
• Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4
  Nature Medicine, 2002
• Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding
  Alimentary Pharmacology & Therapeutics, 2002
• Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways
  Journal of Clinical Investigation, 2001
• Identification of a Human Enterocyte Lipoxin A4 Receptor That Is Regulated by Interleukin (IL)-13 and Interferon γ and Inhibits Tumor Necrosis Factor α–induced IL-8 Release
  The Journal of Experimental Medicine, 1998
• Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
  Gastroenterology, 1997
• Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers.
  Journal of Clinical Investigation, 1993